Top Markets
#1 MowCat MowCat +367.92%
#2 龙虾 (Lobster) 龙虾 (Lobster) +75.81%
#3 Cortex Cortex +31.86%
#4 DexNet DexNet +23.19%
#5 OpenEden OpenEden +19.35%
#6 Akedo Akedo +18.27%
#7 MarsCoin MarsCoin +17.92%
#8 Magma Finance Magma Finance +17.81%
#9 Pons Pons +14.45%
#10 MANTRA MANTRA +14.20%
Coin of the day
MowCat MowCat
設定
言語
日本
通貨
USD
テーマ
Hualan Biological Bacterin Inc. Hualan Biological Bacterin Inc.

Hualan Biological Bacterin Inc.

301207
株式のランク #7577
Hualan Biological Bacterin Inc. is a Chinese pharmaceutical company focused on... Hualan Biological Bacterin Inc. is a Chinese pharmaceutical company focused on the entire vaccine lifecycle, from research and development to manufacturing and sales within China. The company's product line features a diverse range of immunizations, including various influenza virus vaccines (such as split, quadrivalent, and H1N1 strains), recombinant hepatitis B vaccines, and meningococcal polysaccharide vaccines (including ACYW135 and Group A & C types). They also develop genetically engineered vaccines for human use. Established in 2005, Hualan Biological Bacterin Inc. is headquartered in Xinxiang, China, and previously operated as a subsidiary of Hualan Biological Engineering Inc.
株価
$2.58
時価総額
$1.54B
変化（1日）
-2.46%
変化（1年）
2.58%
国
CN
取引 Hualan Biological Bacterin Inc. (301207)

カテゴリー

Healthcare
Hualan Biological Bacterin Inc.（301207）のP/S比率
2026 時点のP/S比率 TTM: 0
Hualan Biological Bacterin Inc. の最新の財務報告および株価によると、現在のP/S比率（TTM）は 0 です。2026 年末時点でのP/S比率は 0 でした。
Hualan Biological Bacterin Inc. の P/S 比率の履歴（2026 ～ 2026）
各年末時点のP/S比率
年 P/S比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/S比率
企業 P/S比率 P/S比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH